+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Deep Vein Thrombosis (DVT) Market Analysis 2019

  • ID: 4857837
  • Report
  • November 2019
  • Region: Global
  • 168 pages
  • Syngene Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Astellas Pharma
  • Bayer
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Daiichi Sankyo
  • MORE
The Global Deep Vein Thrombosis (DVT) Market is poised to grow at a CAGR of around 10.5% over the next decade during 2018 to 2026. Deep vein thrombosis (DVT) is the blood clot that develops in the deep veins of the body. It typically occurs in the lower leg, but it can occur in other body parts too. It results in severe leg pain or swelling and shortness of breath. Sometimes, it occurs without symptoms too.

Factors such as the increasing prevalence of obesity, change in lifestyle of people across the globe, and the rising ageing population are driving the market growth. Though, lack of patient education restrains the market growth. Moreover, advancements in the field of healthcare and increasing government initiatives are the opportunities for the deep vein thrombosis (DVT) market.

Based on treatment, the clot buster segment is going to have a lucrative growth during the forecast period. It is used to break-up the clot that is causing a blockage or disruption in the flow of blood to the brain and helps restore the blood flow to the area of the brain. It is given by intravenous (IV), not by mouth.

The key vendors mentioned are Abbott Laboratories, Johnson & Johnson, Merck & Co, Pfizer, Astellas Pharma, Bristol-Myers Squibb, Daiichi Sankyo, Sanofi-Aventis, Boehringer Ingelheim, GSK, and Bayer.

Treatments Covered:
  • Inferior Vena Cava Filters
  • Compression Stockings
  • Clot Busters
  • Blood Thinners
Distribution Channels Covered:
  • Hospital Pharmacy
  • Retail Pharmacy
  • E-Commerce
Status Covered:
  • Suspended
  • Ongoing
  • Withdrawn
  • Terminated
  • Completed
Types Covered:
  • Below the Knee
  • Above the Knee
Phases Covered:
  • Phase I
  • Phase II
  • Phase III
Applications Covered:
  • Stockings, Walking, and Repeat Imaging
  • Anticoagulation
  • IVC Filters, Thrombolysis, and Thrombectomy
Regions Covered:
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa
Key Questions Answered in this Report:
  • How this market evolved since the year 2016
  • Market size estimations, forecasts and CAGR for all the segments presented in the scope
  • Key Market Developments and financials of the key players
  • Opportunity Analysis for the new entrants
  • SWOT Analysis of the key players
  • Fastest growing markets analysed during the forecast period

*Please Note: This report will be delivered within 48 hours of ordering.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Astellas Pharma
  • Bayer
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Daiichi Sankyo
  • MORE
1 Market Synopsis

2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources

3 Market Dynamics
3.1 Drivers
3.2 Restraints

4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Deep Vein Thrombosis (DVT) Market, By Treatment
5.1 Introduction
5.2 Inferior Vena Cava Filters
5.3 Compression Stockings
5.4 Clot Busters
5.5 Blood Thinners
5.6 Tissue Plasminogen Activators

6 Global Deep Vein Thrombosis (DVT) Market, By Distribution Channel
6.1 Introduction
6.2 Hospital Pharmacy
6.3 Retail Pharmacy
6.4 E-Commerce

7 Global Deep Vein Thrombosis (DVT) Market, By Status
7.1 Introduction
7.2 Suspended
7.3 Ongoing
7.4 Withdrawn
7.5 Terminated
7.6 Completed

8 Global Deep Vein Thrombosis (DVT) Market, By Type
8.1 Introduction
8.2 Below the Knee
8.3 Above the Knee

9 Global Deep Vein Thrombosis (DVT) Market, By Phase
9.1 Introduction
9.2 Phase I
9.3 Phase II
9.4 Phase III

10 Global Deep Vein Thrombosis (DVT) Market, By Application
10.1 Introduction
10.2 Stockings, Walking, and Repeat Imaging
10.3 Anticoagulation
10.4 IVC Filters, Thrombolysis, and Thrombectomy

11 Global Deep Vein Thrombosis (DVT) Market, By Geography
11.1 North America
11.2 Europe
11.3 Asia Pacific
11.4 South America
11.5 Middle East & Africa

12 Strategic Benchmarking

13 Vendors Landscape
13.1 Abbott Laboratories
13.2 Johnson & Johnson
13.3 Merck & Co
13.4 Pfizer
13.5 Astellas Pharma
13.6 Bristol-Myers Squibb
13.7 Daiichi Sankyo
13.8 Sanofi-Aventis
13.9 Boehringer Ingelheim
13.10 GSK
13.11 Bayer

List of Data Tables
Table 1 Global Deep Vein Thrombosis (DVT) Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Deep Vein Thrombosis (DVT) Market Outlook, By Treatment (2016-2026) ($MN)
Table 3 Global Deep Vein Thrombosis (DVT) Market Outlook, By Inferior Vena Cava Filters (2016-2026) ($MN)
Table 4 Global Deep Vein Thrombosis (DVT) Market Outlook, By Compression Stockings (2016-2026) ($MN)
Table 5 Global Deep Vein Thrombosis (DVT) Market Outlook, By Clot Busters (2016-2026) ($MN)
Table 6 Global Deep Vein Thrombosis (DVT) Market Outlook, By Blood Thinners (2016-2026) ($MN)
Table 7 Global Deep Vein Thrombosis (DVT) Market Outlook, By Distribution Channels (2016-2026) ($MN)
Table 8 Global Deep Vein Thrombosis (DVT) Market Outlook, By Hospital Pharmacy (2016-2026) ($MN)
Table 9 Global Deep Vein Thrombosis (DVT) Market Outlook, By Retail Pharmacy (2016-2026) ($MN)
Table 10 Global Deep Vein Thrombosis (DVT) Market Outlook, By E-Commerce (2016-2026) ($MN)
Table 11 Global Deep Vein Thrombosis (DVT) Market Outlook, By Status (2016-2026) ($MN)
Table 12 Global Deep Vein Thrombosis (DVT) Market Outlook, By Suspended (2016-2026) ($MN)
Table 13 Global Deep Vein Thrombosis (DVT) Market Outlook, By Ongoing (2016-2026) ($MN)
Table 14 Global Deep Vein Thrombosis (DVT) Market Outlook, By Withdrawn (2016-2026) ($MN)
Table 15 Global Deep Vein Thrombosis (DVT) Market Outlook, By Terminated (2016-2026) ($MN)
Table 16 Global Deep Vein Thrombosis (DVT) Market Outlook, By Completed (2016-2026) ($MN)
Table 17 Global Deep Vein Thrombosis (DVT) Market Outlook, By Type (2016-2026) ($MN)
Table 18 Global Deep Vein Thrombosis (DVT) Market Outlook, By Below the Knee (2016-2026) ($MN)
Table 19 Global Deep Vein Thrombosis (DVT) Market Outlook, By Above the Knee (2016-2026) ($MN)
Table 20 Global Deep Vein Thrombosis (DVT) Market Outlook, By Phase (2016-2026) ($MN)
Table 21 Global Deep Vein Thrombosis (DVT) Market Outlook, By Phase I (2016-2026) ($MN)
Table 22 Global Deep Vein Thrombosis (DVT) Market Outlook, By Phase II (2016-2026) ($MN)
Table 23 Global Deep Vein Thrombosis (DVT) Market Outlook, By Phase III (2016-2026) ($MN)
Table 24 Global Deep Vein Thrombosis (DVT) Market Outlook, By Application (2016-2026) ($MN)
Table 25 Global Deep Vein Thrombosis (DVT) Market Outlook, By Stockings, Walking, and Repeat Imaging (2016-2026) ($MN)
Table 26 Global Deep Vein Thrombosis (DVT) Market Outlook, By Anticoagulation (2016-2026) ($MN)
Table 27 Global Deep Vein Thrombosis (DVT) Market Outlook, By IVC Filters, Thrombolysis, and Thrombectomy (2016-2026) ($MN)
Table 28 North America Deep Vein Thrombosis (DVT) Market Outlook, By Country (2016-2026) ($MN)
Table 29 North America Deep Vein Thrombosis (DVT) Market Outlook, By Treatment (2016-2026) ($MN)
Table 30 North America Deep Vein Thrombosis (DVT) Market Outlook, By Distribution Channels (2016-2026) ($MN)
Table 31 North America Deep Vein Thrombosis (DVT) Market Outlook, By Status (2016-2026) ($MN)
Table 32 North America Deep Vein Thrombosis (DVT) Market Outlook, By Type (2016-2026) ($MN)
Table 33 North America Deep Vein Thrombosis (DVT) Market Outlook, By Phase (2016-2026) ($MN)
Table 34 North America Deep Vein Thrombosis (DVT) Market Outlook, By Application (2016-2026) ($MN)
Table 35 Europe Deep Vein Thrombosis (DVT) Market Outlook, By Country (2016-2026) ($MN)
Table 36 Europe Deep Vein Thrombosis (DVT) Market Outlook, By Treatment (2016-2026) ($MN)
Table 37 Europe Deep Vein Thrombosis (DVT) Market Outlook, By Distribution Channels (2016-2026) ($MN)
Table 38 Europe Deep Vein Thrombosis (DVT) Market Outlook, By Status (2016-2026) ($MN)
Table 39 Europe Deep Vein Thrombosis (DVT) Market Outlook, By Type (2016-2026) ($MN)
Table 40 Europe Deep Vein Thrombosis (DVT) Market Outlook, By Phase (2016-2026) ($MN)
Table 41 Europe Deep Vein Thrombosis (DVT) Market Outlook, By Application (2016-2026) ($MN)
Table 42 Asia Pacific Deep Vein Thrombosis (DVT) Market Outlook, By Country (2016-2026) ($MN)
Table 43 Asia Pacific Deep Vein Thrombosis (DVT) Market Outlook, By Treatment (2016-2026) ($MN)
Table 44 Asia Pacific Deep Vein Thrombosis (DVT) Market Outlook, By Distribution Channels (2016-2026) ($MN)
Table 45 Asia Pacific Deep Vein Thrombosis (DVT) Market Outlook, By Status (2016-2026) ($MN)
Table 46 Asia Pacific Deep Vein Thrombosis (DVT) Market Outlook, By Type (2016-2026) ($MN)
Table 47 Asia Pacific Deep Vein Thrombosis (DVT) Market Outlook, By Phase (2016-2026) ($MN)
Table 48 Asia Pacific Deep Vein Thrombosis (DVT) Market Outlook, By Application (2016-2026) ($MN)
Table 49 South America Deep Vein Thrombosis (DVT) Market Outlook, By Country (2016-2026) ($MN)
Table 50 South America Deep Vein Thrombosis (DVT) Market Outlook, By Treatment (2016-2026) ($MN)
Table 51 South America Deep Vein Thrombosis (DVT) Market Outlook, By Distribution Channels (2016-2026) ($MN)
Table 52 South America Deep Vein Thrombosis (DVT) Market Outlook, By Status (2016-2026) ($MN)
Table 53 South America Deep Vein Thrombosis (DVT) Market Outlook, By Type (2016-2026) ($MN)
Table 54 South America Deep Vein Thrombosis (DVT) Market Outlook, By Phase (2016-2026) ($MN)
Table 55 South America Deep Vein Thrombosis (DVT) Market Outlook, By Application (2016-2026) ($MN)
Table 56 Middle East & Africa Deep Vein Thrombosis (DVT) Market Outlook, By Country (2016-2026) ($MN)
Table 57 Middle East & Africa Deep Vein Thrombosis (DVT) Market Outlook, By Treatment (2016-2026) ($MN)
Table 58 Middle East & Africa Deep Vein Thrombosis (DVT) Market Outlook, By Distribution Channels (2016-2026) ($MN)
Table 59 Middle East & Africa Deep Vein Thrombosis (DVT) Market Outlook, By Status (2016-2026) ($MN)
Table 60 Middle East & Africa Deep Vein Thrombosis (DVT) Market Outlook, By Type (2016-2026) ($MN)
Table 61 Middle East & Africa Deep Vein Thrombosis (DVT) Market Outlook, By Phase (2016-2026) ($MN)
Table 62 Middle East & Africa Deep Vein Thrombosis (DVT) Market Outlook, By Application (2016-2026) ($MN)
Note: Product cover images may vary from those shown
3 of 3
  • Abbott Laboratories
  • Johnson & Johnson
  • Merck & Co
  • Pfizer
  • Astellas Pharma
  • Bristol-Myers Squibb
  • Daiichi Sankyo
  • Sanofi-Aventis
  • Boehringer Ingelheim
  • GSK
  • Bayer
Note: Product cover images may vary from those shown
Adroll
adroll